Epley manoeuvre for posterior semicircular canal benign paroxysmal positional vertigo in people with multiple sclerosis: protocol of a randomised controlled trial

Cristina García-Muñoz, María-Dolores Cortés-Vega, Juan Carlos Hernández-Rodríguez, Rocio Palomo-Carrión, Rocío Martín-Valero, María Jesús Casuso-Holgado, Cristina García-Muñoz, María-Dolores Cortés-Vega, Juan Carlos Hernández-Rodríguez, Rocio Palomo-Carrión, Rocío Martín-Valero, María Jesús Casuso-Holgado

Abstract

Introduction: Vestibular disorders in multiple sclerosis (MS) could have central or peripheral origin. Although the central aetiology is the most expected in MS, peripheral damage is also significant in this disease. The most prevalent effect of vestibular peripheral damage is benign paroxysmal positional vertigo (BPPV). Impairments of the posterior semicircular canals represent 60%-90% of cases of BPPV. The standard gold treatment for this syndrome is the Epley manoeuvre (EM), the effectiveness of which has been poorly studied in patients with MS. Only one retrospective research study and a case study have reported encouraging results for EM with regard to resolution of posterior semicircular canal BPPV. The aim of this future randomised controlled trial (RCT) is to assess the effectiveness of EM for BPPV in participants with MS compared with a sham manoeuvre.

Methods and analysis: The current protocol describes an RCT with two-arm, parallel-group design. Randomisation, concealed allocation and double-blinding will be conducted to reduce possible bias. Participants and evaluators will be blinded to group allocation. At least 80 participants who meet all eligibility criteria will be recruited. Participants will have the EM or sham manoeuvre performed within the experimental or control group, respectively. The primary outcome of the study is changes in the Dix Hallpike test. The secondary outcome will be changes in self-perceived scales: Dizziness Handicap Inventory and Vestibular Disorders Activities of Daily Living Scale. The sample will be evaluated at baseline, immediately after the intervention and 48 hours postintervention.

Ethics and dissemination: The study was approved by the Andalusian Review Board and Ethics Committee of Virgen Macarena-Virgen del Rocio Hospitals (ID 0107-N-20, 23 July 2020). The results of the research will be disseminated by the investigators to peer-reviewed journals.

Trial registration number: NCT04578262.

Keywords: neurology; otolaryngology; rehabilitation medicine.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
CONSORT flow diagram of participants’ recruitment and progress through the phases of the trial. CONSORT, Consolidated Standards of Reporting Trials; CG, control group; EC, experimental group.

References

    1. Tafti D, Ehsan M, Xixis KL. Multiple Sclerosis. StatPearls Publishing, 2020.
    1. Wallin MT, Culpepper WJ, Nichols E, et al. . Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 2019;18:269–85. 10.1016/S1474-4422(18)30443-5
    1. Gossman W, Ehsan M, Xixis KL. Multiple Sclerosis, 2019.
    1. Marrie RA, Cutter GR, Tyry T. Substantial burden of dizziness in multiple sclerosis. Mult Scler Relat Disord 2013;2:21–8. 10.1016/j.msard.2012.08.004
    1. Kutz JW. The dizzy patient. Med Clin North Am 2010;94:989–1002. 10.1016/j.mcna.2010.05.011
    1. Doty RL, MacGillivray MR, Talab H, et al. . Balance in multiple sclerosis: relationship to central brain regions. Exp Brain Res 2018;236:2739–50. 10.1007/s00221-018-5332-1
    1. Alpini D, Caputo D, Pugnetti L, et al. . Vertigo and multiple sclerosis: aspects of differential diagnosis. Neurol Sci 2001;22 Suppl 2:S84–7. 10.1007/s100720100041
    1. Alpini D, Berardino FD, Mattei V, et al. . Characteristics of multiple sclerosis patient stance control disorders, measured by means of posturography and related to brainstem lesions. Audiol Res 2012;2:43–7. 10.4081/audiores.2012.e9
    1. Frohman EM, Kramer PD, Dewey RB, et al. . Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniques. Mult Scler 2003;9:250–5. 10.1191/1352458503ms901oa
    1. Soto-Varela A, Santos-Perez S, Rossi-Izquierdo M, et al. . Are the three canals equally susceptible to benign paroxysmal positional vertigo? Audiol Neurootol 2013;18:327–34. 10.1159/000354649
    1. Instrum RS, Parnes LS. Benign paroxysmal positional vertigo. Adv Otorhinolaryngol 2019;82:67–76. 10.1159/000490273
    1. Balatsouras DG. Benign paroxysmal positional vertigo with multiple canal involvement. Am J Otolaryngol 2012;33:250–8. 10.1016/j.amjoto.2011.07.007
    1. Zeigelboim BS, Arruda WO, Mangabeira-Albernaz PL, et al. . Vestibular findings in relapsing, remitting multiple sclerosis: a study of thirty patients. Int Tinnitus J 2008;14:139–45.
    1. Frohman TC, O’ donghue DL, Northrop D. Multiple Sclerosis for the Physician Assistant. In: Multiple Sclerosis for the Physician Assistant. National Multiple Sclerosis Society 2011:138–41.
    1. Song MH, Kong TH, Shim DB. Optimal reassessment time for treatment response in posterior canal benign paroxysmal positional vertigo. Laryngoscope 2019:1–4.
    1. Kollén L, Bjerlemo B, Möller C. Evaluation of treatment in benign paroxysmal positional vertigo (BPPV). Adv Physiother 2006;8:106–15. 10.1080/14038190600836866
    1. Lindell E, Kollén L, Johansson M. Benign paroxysmal positional vertigo, dizziness, and health-related quality of life among older adults in a population-based setting. Eur Arch Oto-Rhino-Laryngology.
    1. Bhattacharyya N, Gubbels SP, Schwartz SR, et al. . Clinical practice guideline: benign paroxysmal positional vertigo (update). Otolaryngol Head Neck Surg 2017;156:S1–47. 10.1177/0194599816689667
    1. Strupp M, Mandalà M, López-Escámez JA. Peripheral vestibular disorders: an update. Curr Opin Neurol 2019;32:165–73. 10.1097/WCO.0000000000000649
    1. Ciorba A, Cogliandolo C, Bianchini C, et al. . Clinical features of benign paroxysmal positional vertigo of the posterior semicircular canal. SAGE Open Med 2019;7:205031211882292. 10.1177/2050312118822922
    1. Ballvé JL, Carrillo-Muñoz R, Rando-Matos Y, et al. . Effectiveness of the Epley manoeuvre in posterior canal benign paroxysmal positional vertigo: a randomised clinical trial in primary care. Br J Gen Pract 2019;69:e52–60. 10.3399/bjgp18X700253
    1. Mandalà M, Salerni L, Nuti D. Benign positional paroxysmal vertigo treatment: a practical update. Curr Treat Options Neurol 2019;21:66. 10.1007/s11940-019-0606-x
    1. Dix MR, Hallpike S, Meniere P. The pathology, symptomatology and diagnosis of certain common disorders of the vestibular system, 1952.
    1. Lin HC, Shu MT, Shi SM. The canalith repositioning procedure for benign paroxysmal positional vertigo. J Taiwan Otolaryngol - Head Neck Surg 1999;34:379–84.
    1. Gupta AK, Sharma KG, Sharma P. Effect of Epley, Semont maneuvers and Brandt-Daroff exercise on quality of life in patients with posterior semicircular canal benign paroxysmal positional vertigo (PSCBPPV). Indian J Otolaryngol Head Neck Surg 2019;71:99–103. 10.1007/s12070-018-1322-7
    1. Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 1992;107:399–404. 10.1177/019459989210700310
    1. Hunt WT, Zimmermann EF, Hilton MP. Modifications of the Epley (canalith repositioning) manoeuvre for posterior canal benign paroxysmal positional vertigo (BPPV). Cochrane Database Syst Rev 2012;Published Online First.
    1. Frohman EM, Zhang H, Dewey RB, et al. . Vertigo in MS: utility of positional and particle repositioning maneuvers. Neurology 2000;55:1566–9. 10.1212/WNL.55.10.1566
    1. Ling X, Zhao D-H, Shen B, et al. . Clinical characteristics of patients with benign paroxysmal positional vertigo diagnosed based on the diagnostic criteria of the Bárány Society. Front Neurol 2020;11. 10.3389/fneur.2020.00602
    1. Power L, Murray K, Szmulewicz DJ. Characteristics of assessment and treatment in benign paroxysmal positional vertigo (BPPV). VES 2020;30:55–62. 10.3233/VES-190687
    1. Yoosefinejad AK, Siravani F. Semont and Epley maneuvers alleviated vertigo in a patient with multiple sclerosis. Heal Sci J 2015;9:1–3.
    1. Chan A-W, Tetzlaff JM, Altman DG, et al. . Spirit 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583
    1. Schulz KF, Altman DG, CONSORT MD. Statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;2010:726–32.
    1. Hilton MP, Pinder DK. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev 2014;2014:CD003162. 10.1002/14651858.CD003162.pub3
    1. Bruintjes TD, Companjen J, van der Zaag-Loonen HJ, et al. . A randomised sham-controlled trial to assess the long-term effect of the Epley manoeuvre for treatment of posterior canal benign paroxysmal positional vertigo. Clin Otolaryngol 2014;39:39–44. 10.1111/coa.12217
    1. Maslovara S, Vešligaj T, Soldo SB. Importance of accurate diagnosis in benign paroxysmal positional vertigo (BPPV) therapy. Med Glas 2014;11:300–6.
    1. VanDerHeyden CM, Carender WJ, Heidenreich KD. Nystagmus discordance with 2-dimensional videonystagmography in posterior semicircular canal benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2015;152:724–8. 10.1177/0194599814564373
    1. Falls C. Videonystagmography and posturography. Adv Otorhinolaryngol 2019;82:32–8. 10.1159/000490269
    1. Shah S, Vishwakarma R. Role of Videonystagmography (VNG) in Epley’s Maneuver. Int J Otolaryngol Head 2014;03:311–7.
    1. Kinne BL. Benign paroxysmal positional vertigo eye Mov Disord (nystagmus strabismus) diagnosis. Manag Impact Qual Life 2014:1–30.
    1. Rizk H, Agrawal Y, Barthel S, et al. . Quality improvement in neurology: neuro-otology quality measurement set. Neurology 2018;91:697–701. 10.1212/WNL.0000000000006217
    1. Dunlap PM, Holmberg JM, Whitney SL. Vestibular rehabilitation: advances in peripheral and central vestibular disorders. Curr Opin Neurol 2019;32:137–44. 10.1097/WCO.0000000000000632
    1. Martens C, Goplen FK, Aasen T, et al. . Dizziness handicap and clinical characteristics of posterior and lateral canal BPPV. Eur Arch Otorhinolaryngol 2019;276:2181–9. 10.1007/s00405-019-05459-9
    1. Domingues R, Waseem M. Dix-Hallpike Maneuver. : Atlas of emergency medicine procedures. Springer New York, 2016: 257–8.
    1. Tamber A-L, Wilhelmsen KT, Strand LI. Measurement properties of the dizziness handicap inventory by cross-sectional and longitudinal designs. Health Qual Life Outcomes 2009;7:1–16. 10.1186/1477-7525-7-101
    1. Cattaneo D, Jonsdottir J, Repetti S. Reliability of four scales on balance disorders in persons with multiple sclerosis. Disabil Rehabil 2007;29:1920–5. 10.1080/09638280701191859
    1. Harun A, Semenov YR, Agrawal Y. Vestibular function and activities of daily living. Gerontology and Geriatric Medicine 2015;1:233372141560712. 10.1177/2333721415607124
    1. Cohen HS. Use of the vestibular disorders activities of daily living scale to describe functional limitations in patients with vestibular disorders. J Vestib Res 2014;24:33–8. 10.3233/VES-130475
    1. Cohen HS, Kimball KT, Adams AS. Application of the vestibular disorders activities of daily living scale. Laryngoscope 2000;110:1204–9. 10.1097/00005537-200007000-00026
    1. Faul F, Erdfelder E, Lang AG. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. In: Behavior Research Methods. Psychonomic Society Inc 2007:175–91.
    1. Kieser M. Methods and applications of sample size calculation and Recalculation in clinical trials. Springer.
    1. Verma JP, Verma P. Determining sample size and power in research studies. Springer Singapore, 2020.
    1. Marsden J, Pavlou M, Dennett R. Vestibular rehabilitation in multiple sclerosis: study protocol for a randomised controlled trial and cost-effectiveness analysis comparing customised with booklet based vestibular rehabilitation for vestibulopathy and a 12 month observational cohort stud. BMC Neurol 2020;20:1–15.
    1. Thomas DB, Newman-Toker DE. Diagnosis is a team sport – partnering with allied health professionals to reduce diagnostic errors. Diagnosis 2016;3:49–59. 10.1515/dx-2016-0009
    1. Thabet EM, Abdelkhalek A, Zaghloul H. Superior semicircular canal dehiscence syndrome as assessed by oVEMP and temporal bone computed tomography imaging. Eur Arch Otorhinolaryngol 2012;269:1545–9. 10.1007/s00405-011-1893-3
    1. Di Stadio A, Dipietro L, Ralli M, et al. . The role of vestibular evoked myogenic potentials in multiple sclerosis-related vertigo. A systematic review of the literature. Mult Scler Relat Disord 2019;28:159–64. 10.1016/j.msard.2018.12.031
    1. Korres S, Riga M, Papacharalampous G, et al. . Relative diagnostic importance of electronystagmography and magnetic resonance imaging in vestibular disorders. J Laryngol Otol 2009;123:851–6. 10.1017/S0022215109004630
    1. Esra E, Mecidiyekoy O, Hastanesi C. Importance of accurate diagnosis in benign paroxysmal positional vertigo with Videonstagmography and the success rate of the maneuvers, 2017.
    1. Mohamed ES. Predictors of central vestibular disorders from videonystagmography tests. Egypt J Otolaryngol 2016;32:202–9. 10.4103/1012-5574.186534
    1. Woo D, Frohman TC, Frohman EM. Vestibular testing and multiple sclerosis. Handb Clin Neurophysiol 2010;9:478–86.
    1. Di Stadio A, Ralli M. Inner ear involvement in multiple sclerosis: an underestimated condition? Mult Scler 2018;24:1264–5. 10.1177/1352458517750010
    1. Cetin YS, Ozmen OA, Demir UL, et al. . Comparison of the effectiveness of Brandt-Daroff vestibular training and Epley canalith repositioning maneuver in benign paroxysmal positional vertigo long term result: a randomized prospective clinical trial. Pak J Med Sci 2018;34:558–63. 10.12669/pjms.343.14786

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe